Lymph node dissection after neoadjuvant chemotherapy improves overall survival in clinical stage III endometrial cancer | International Journal of Gynecologic Cancer

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About

YouTube

Podcasts

Zoom Journal Club
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

other Versions

You are currently viewing an earlier version of this article (June 30, 2024).
View the most recent version of this article

Original research

Lymph node dissection after neoadjuvant chemotherapy improves overall survival in clinical stage III endometrial cancer

Online download statistics by month:

Online download statistics by month: June 2024 to November 2024

	Abstract	Full	Pdf
Jun 2024	78	2	1
Jul 2024	647	23	11
Aug 2024	160	11	6
Sep 2024	89	3	4
Oct 2024	102	10	7
Nov 2024	697	58	34
Total	1773	107	63